Cargando…
Exogenous Flupirtine as Potential Treatment for CLN3 Disease
CLN3 disease is a fatal neurodegenerative disorder affecting children. Hallmarks include brain atrophy, accelerated neuronal apoptosis, and ceramide elevation. Treatment regimens are supportive, highlighting the importance of novel, disease-modifying drugs. Flupirtine and its new allyl carbamate der...
Autores principales: | Maalouf, Katia, Makoukji, Joelle, Saab, Sara, Makhoul, Nadine J., Carmona, Angelica V., Kinarivala, Nihar, Ghanem, Noël, Trippier, Paul C., Boustany, Rose-Mary |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464162/ https://www.ncbi.nlm.nih.gov/pubmed/32796515 http://dx.doi.org/10.3390/cells9081872 |
Ejemplares similares
-
Flupirtine derivatives as potential treatment for the neuronal ceroid lipofuscinoses
por: Makoukji, Joelle, et al.
Publicado: (2018) -
Sex differences in gene expression with galactosylceramide treatment in Cln3(Δex7/8) mice
por: Makoukji, Joelle, et al.
Publicado: (2020) -
Developmental Comparison of Ceramide in Wild-Type and Cln3(Δex7/8) Mouse Brains and Sera
por: El-Sitt, Sally, et al.
Publicado: (2019) -
Association between CLN3 (Neuronal Ceroid Lipofuscinosis, CLN3 Type) Gene Expression and Clinical Characteristics of Breast Cancer Patients
por: Makoukji, Joelle, et al.
Publicado: (2015) -
RYR2, PTDSS1 and AREG genes are implicated in a Lebanese population-based study of copy number variation in autism
por: Soueid, Jihane, et al.
Publicado: (2016)